BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $84,233 | +24.8% | 13,630 | +2.6% | 0.00% | – |
| Q1 2024 | $67,488 | -0.8% | 13,285 | +106.9% | 0.00% | – |
| Q2 2022 | $68,000 | -36.4% | 6,421 | -2.5% | 0.00% | -100.0% |
| Q1 2022 | $107,000 | +23.0% | 6,587 | +5.5% | 0.00% | 0.0% |
| Q4 2021 | $87,000 | -22.3% | 6,246 | -20.1% | 0.00% | 0.0% |
| Q3 2021 | $112,000 | +36.6% | 7,817 | +50.5% | 0.00% | 0.0% |
| Q2 2021 | $82,000 | +54.7% | 5,193 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $53,000 | +20.5% | 5,193 | -11.2% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | +76.0% | 5,850 | -17.6% | 0.00% | – |
| Q3 2020 | $25,000 | +47.1% | 7,100 | +104.5% | 0.00% | – |
| Q2 2020 | $17,000 | – | 3,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |